Oligodendrocyte apoptosis and primary demyelination induced by local TNF/p55TNF receptor signaling in the central nervous system of transgenic mice: Models for multiple sclerosis with primary oligodendrogliopathy

American Journal of Pathology

Volumn 153, Issue 3, 1998, Pages 801-813

  Akassoglou, Katerina ^a   Bauer, Jan ^b   Kassiotis, George ^a   Pasparakis, Manolis ^a   Lassmann, Hans ^b   Kollias, George ^a   Probert, Lesley ^a  

^a HELLENIC PASTEUR INSTITUTE   (Greece)

^b MEDICAL UNIVERSITY OF VIENNA   (Austria)

Author keywords

[No Author keywords available]

Indexed keywords

DNA FRAGMENT; DNA NUCLEOTIDYLEXOTRANSFERASE; LIGAND; MYELIN; TUMOR NECROSIS FACTOR; TUMOR NECROSIS FACTOR RECEPTOR;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; APOPTOSIS; ARTICLE; BLOOD BRAIN BARRIER; CENTRAL NERVOUS SYSTEM; CONTROLLED STUDY; DEMYELINATION; MOUSE; MULTIPLE SCLEROSIS; NONHUMAN; OLIGODENDROGLIA; PRIORITY JOURNAL; SIGNAL TRANSDUCTION; TRANSGENIC MOUSE;

EID: 0031659763     PISSN: 00029440     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0002-9440(10)65622-2     Document Type: Article

References (70)

1. Martin R, McFarland HF, McFarlin DE: Immunological aspects of demyelinating diseases. Annu Rev Immunol 1992, 10:153-187
2. Brosnan CF, Raine CS: Mechanisms of immune injury in multiple sclerosis. Brain Pathol 1996, 6:243-257
3. Lucchinetti CF, Bruck W, Rodriguez M, Lassmann H: Distinct patterns of multiple sclerosis pathology indicates heterogeneity in pathogenesis. Brain Pathol 1996, 6:259-274
4. Dowling P, Shang G, Raval S, Menonna J, Cook S, Husar W: Involvement of the CD95 (APO-1/Fas) receptor/ligand system in multiple sclerosis brain. J Exp Med 1996, 184:1513-1518
5. Vartanian T, Li Y, Zhao M, Stefansson K: Interferon-γ induced oligodendrocytes cell death: implications for the pathogenesis of multiple sclerosis. Mol Med 1995, 1:732-743
6. D'Souza SD, Bonetti B, Balasingam V, Cashman NR, Barker PA, Troutt AB, Raine CS, Antel JP: Multiple sclerosis: Fas signaling in oligodendrocyte cell death. J Exp Med 1996, 184:2361-2370
7. Zamvil SS, Steinman L: The T lymphocyte in experimental allergic encephalomyelitis. Annu Rev Immunol 1990, 8:579-621
8. Wekerle H, Kojima K, Lannes-Vieira J, Lassmann H, Linington C: Animal models. Ann Neurol 1994, 36:S47-S53
9. Genain CP, Nguyen MH, Letvin NL, Pearl R, Davis RL, Adelman M, Lees MB, Linington C, Hauser SL: Antibody facilitation of multiple sclerosis-like lesions in a nonhuman primate. J Clin Invest 1995, 96:2966-2974
10. Dal Canto MC, Melvold RW, Kim BS, Miller SD: Two models of multiple sclerosis experimental allergic encephalomyelitis (EAE) and Theiler's murine encephalomyelitis virus (TMEV) infection; a pathological and immunological comparison. Microsc Res Tech 1995, 32:215-229
11. Rodriguez M, Pavelko KD, Njjenga MK, Logan WC, Wettstein PJ: The balance between persistent virus infection and immune cells determines demyelination. J Immunol 1996, 157:5699-5709
12. Raine CS: Multiple sclerosis: TNF revisited, with promise. Nat Med 1995, 1:211-214
13. Hofman FM, Hinton DR, Johnson K, Merrill JE: Tumor necrosis factor identified in multiple sclerosis brain. J Exp Med 1989, 170:607-612
14. Selmaj KW, Raine CS, Cannella B, Brosnan CF: Identification of lymphotoxin and tumor necrosis factor in multiple sclerosis lesions. J Clin Invest 1991, 87:949-954
15. Bonetti B, Raine CS: Multiple sclerosis: oligodendrocytes display cell death-related molecules in situ but do not undergo apoptosis. Ann Neurol 1997, 42:74-84
16. Sharief MK, Hentges R: Association between tumor necrosis factor-α and disease progression in patients with multiple sclerosis. N Engl J Med 1991, 325:467-472
17. Selmaj KW, Farooq M, Norton WT, Raine CS, Brosnan CF: Proliferation of astrocytes in vitro in response to cytokines: a primary role for tumor necrosis factor. J Immunol 1990, 144:129-135
18. Merrill J: Effects of interleukin-1 and tumor necrosis factor-α on astrocytes, microglia, oligodendrocytes, and glial precursors in vitro. Dev Neurosci 1991, 13:130-137
19. Karmann K, Min W, Fanslow WC, Pober JS: Activation and homologous desensitization of human endothelial cells by CD40 ligand, tumor necrosis factor, and interleukin 1. J Exp Med 1996, 184:173-182
20. Shrikant P, Benveniste EN: The central nervous system as an immunocompetent organ: role of glial cells in antigen presentation. J Immunol 1996, 157:1819-1822
21. Merrill JE, Benveniste EN: Cytokines in inflammatory brain lesions: helpful and harmful. Trends Neurosci 1996, 19:331-338
22. Selmaj KW, Raine CS: Tumor necrosis factor mediates myelin and oligodendrocyte damage in vitro. Ann Neurol 1988, 23:339-346
23. Selmaj K, Raine CS, Farooq M, Norton WT, Brosnan CF: Cytokine cytotoxicity against oligodendrocytes: apoptosis induced by lymphotoxin. J Immunol 1991, 147:1522-1529
24. Hisahara S, Shoji S, Okano H, Miura M: ICE/CED-3 family executes oligodendrocyte apoptosis by tumor necrosis factor. J Neurochem 1997, 69:10-20
25. Ruddle NH, Bergman CM, McGrath KM, Lingenheld EG, Grunnet ML, Padula SJ, Clark RB: An antibody to lymphotoxin and tumor necrosis factor prevents transfer of experimental allergic encephalomyelitis. J Exp Med 1990, 172:1193-1200
26. Baker D, Butler D, Scallon BJ, O'Neill JK, Turk JL, Feldmann M: Control of established experimental allergic encephalomyelitis by inhibition of tumor necrosis factor (TNF) activity within the central nervous system using monoclonal antibodies and TNF receptor-immunoglobulin fusion proteins. Eur J Immunol 1994, 24:2040-2048
27. Selmaj K, Papierz W, Glabinski A, Kohno T: Prevention of chronic relapsing experimental autoimmune encephalomyelitis by soluble tumor necrosis factor receptor I. J Neuroimmunol 1995, 56:135-141
28. Sommer N, Loschmann P-A, Northoff GH, Weller M, Steinbrecher A, Steinbach JP, Lichtenfels R, Meyermann R, Riethmuller A, Fontana A, Dichgans J, Martin R: The antidepressant rolipram suppresses cytokine production and prevents autoimmune encephalomyelitis. Nat Med 1995, 1:244-248
29. Frei K, Eugster H-P, Bopst M, Constantinescu CS, Lavi E, Fontana A: Tumor necrosis factor α and lymphotoxin α are not required for induction of acute experimental autoimmune encephalomyelitis. J Exp Med 1997, 185:2177-2182
30. Suen WE, Bergman CM, Hjelmstrom P, Ruddle NH: A critical role for lymphotoxin in experimental allergic encephalomyelitis. J Exp Med 1997, 186:1233-1240
31. Korner H, Rimington DS, Strickland DH, Lemckert FA, Pollard JD, Sedgwick JD: Critical points of tumor necrosis factor action in central nervous system autoimmune inflammation defined by gene targeting. J Exp Med 1997, 186:1585-1590
32. Liu J, Marino MW, Wong G, Grail D, Dunn A, Bettadapura J, Slavin AJ, Old L, Bernard CCA: TNF is a potent anti-inflammatory cytokine in autoimmune-mediated demyelination. Nat Med 1998, 4:78-83
33. Steinman L: Some misconceptions about understanding autoimmunity through experiments with knockouts. J Exp Med 1997, 185:2039-2041
34. Rodriguez M, Scheithauer B: Ultrastructure of multiple sclerosis. Ultrastruct Pathol 1994, 18:3-13
35. Probert L, Akassoglou K, Pasparakis M, Kontogeorgos G, Kollias G: Spontaneous inflammatory demyelinating disease in transgenic mice showing central nervous system-specific expression of tumor necrosis factor α. Proc Natl Acad Sci USA 1995, 92:11294-11298
36. Akassoglou K, Probert L, Kontogeorgos G, Kollias G: Astrocyte-specific but not neuron-specific transmembrane TNF triggers inflammation and degeneration in the central nervous system of transgenic mice. J Immunol 1997, 158:438-445
37. Rothe J, Lesslauer W, Lotscher H, Lang Y, Koebel P, Kontgen F, Althage A, Zinkernagel R, Steinmetz M, Bluethmann H: Mice lacking the tumour necrosis factor receptor 1 are resistant to TNF-mediated toxicity but highly susceptible to infection by Listeria monocytogenes. Nature 1993, 364:798-802
38. Erickson SL, de Sauvage FJ, Kikly K, Carver-Moore K, Pitts-Meek S, Gillet N, Sheehan KF, Schreiber RD, Goeddel DV, Moore MW: Decreased sensitivity to tumour-necrosis factor but normal T-cell development in TNF receptor-2-deficient mice. Nature 1994, 372:560-563
39. Pasparakis M, Alexopoulou L, Episkopou V, Kollias G: Immune and inflammatory responses in TNF α-deficient mice: a critical requirement for TNF α in the formation of primary B cell follicles, follicular dendritic cell networks and germinal centers, and in the maturation of the humoral immune response. J Exp Med 1996, 184:1397-1411
40. Rossler K, Neuchrist C, Kitz K, Scheiner O, Kraft D, Lassmann H: Expression of leucocyte adhesion molecules at the human blood-brain barrier. J Neurosci Res 1992, 31:365-374
41. Gold R, Schmied M, Giegerich G, Breitschopf H, Hartung HP, Toyka KV, Lassmann H: Differentiation between cellular apoptosis and necrosis by the combined use of in situ tailing and nick translation techniques. Lab Invest 1994, 71:219-225
42. Breitschopf H, Suchanek G, Gould RM, Coleman DR, Lassmann H: In situ hybridization with digoxigenin-labeled probes: sensitive and reliable detection method applied to myelinating rat brain. Acta Neuropathol 1992, 84:581-587
43. Stagaard Janas M, Nowakowski RS, Terkelsen OB, Mollgard K: Glial cell differentiation in neuron-free and neuron-rich regions. I. Selective appearance of S-100 protein in radial glial cells of the hippocampal fimbria in human fetuses. Anat Embryol (Berl) 1991, 184:549-558
44. Maier H, Budka H, Lassmann H, Pohl P: Vacuolar myelopathy with multinucleated giant cells in the aquired immune deficiency syndrome (AIDS): light and electron microscopic distribution of human immunodeficiency virus (HIV) antigens. Acta Neuropathol 1989, 78: 497-503
45. Raine CS: Demyelinating diseases. Textbook of Neuropathology. Edited by RL Davies, DM Robertson. Baltimore, Williams and Wilkins, 1997, pp 627-714
46. Lewis M, Tartaglia LA, Lee A, Bennett GL, Rice GC, Wong GHW, Chen EY, Goeddel DV: Cloning and expression of cDNAs for two distinct murine tumor necrosis factor receptors demonstrate one receptor is species specific. Proc Natl Acad Sci USA 1991, 88:2830-2834
47. Ozawa K, Suchanek G, Breitschopf H, Bruck W, Budka H, Jellinger K, Lassmann H: Patterns of oligodendroglia pathology in multiple sclerosis. Brain 1994, 117:1311-1322
48. Bruck W, Schmied M, Suchanek G, Bruck Y, Breitschopf H, Poser S, Piddlesden S, Lassmann H: Oligodendrocytes in the early course of multiple sclerosis. Ann Neurol 1994, 35:65-73
49. Raine CS: Multiple sclerosis: a pivotal role for the T cell in lesion development. Neuropathol Appl Neurobiol 1991, 17:265-274
50. Link H, Baig S, Olsson O, Yu-Ping J, Hojeberg B, Olsson T: Persistent anti-myelin basic protein IgG antibody response in multiple sclerosis cerebrospinal fluid. J Neuroimmunol 1990, 28:237-248
51. Genain CP, Abel K, Belmar N, Villinger F, Rosenberg DP, Linington C, Raine CS, Hauser SL: Late complications of immune deviation therapy in a nonhuman primate. Science 1996, 274:2054-2057
52. Bonetti B, Pohl J, Gao Y-L, Raine CS: Cell death during autoimmune demyelination: effector but not target cells are eliminated by apoptosis. J Immunol 1997, 159:5733-5741
53. Vassalli P: The pathophysiology of tumor necrosis factors. Annu Rev Immunol 1992, 10:411-452
54. Sarvetnick N: Mechanisms of cytokine-mediated localized immunoprotection. J Exp Med 1996, 184:1597-1600
55. Cope A, Liblau RS, Yang X-D, Congia M, Laudanna C, Schreiber RD, Probert L, Kollias G, McDevitt HO: Chronic tumor necrosis factor alters T cell responses by attenuating T cell receptor signaling. J Exp Med 1997, 185:1573-1584
56. Tyor WR, Glass JD, Baumrind N, McArthur JC, Griffin JW, Becker PS, Griffin DE: Cytokine expression of macrophages in HIV-1-associated vacuolar myelopathy. Neurology 1993, 43:1002-1009
57. Wilt SG, Milward E, Zhou JM, Nagasato K, Patton H, Rusten R, Griffin DE, O'Connor M, and Dubois-Dalcq M: In vitro evidence for a dual role of tumor necrosis factor-α in human immunodeficiency virus type 1 encephalopathy: Ann Neurol 1995, 37:381-394
58. Kordek R, Nerurkar VR, Liberski PP, Isaacson S, Yanagihara R, Gajdusek DC: Heightened expression of tumor necrosis factor α, interleukin 1α, and glial fibrillary acidic protein in experimental Creutzfeldt-Jakob disease in mice. Proc Natl Acad Sci USA 1996, 93:9754-9758
59. Liu Z-G, Hsu H, Goeddel DV, Karin M: Dissection of TNF receptor 1 effector functions: JNK activation is not linked to apoptosis while NF-κB activation prevents cell death. Cell 1996, 87:565-576
60. Wallach D, Boldin M, Varfolomeev E, Beyaert R, Vandenbeele P, Fiers W: Cell death induction by receptors of the TNF family: towards a molecular understanding. FEBS Lett 1997, 410:96-106
61. Beg AA, Baltimore D: An essential role for NF-κB in preventing TNF-α-induced cell death. Science 1996, 274:782-784
62. Van Antwerp DJ, Martin SJ, Kafri T, Green DR, Verma IM: Suppression of TNF-α-induced apoptosis by NF-κB. Science 1996, 274:787-789
63. Dopp JM, Mackenzie-Graham A, Otero GC, Merrill JE: Differential expression, cytokine modulation, and specific functions of type-1 and type-2 tumor necrosis factor receptors in rat glia. J Neuroimmunol 1997, 75:104-112
64. Tchelingerian JL, Monge M, Le Saux F, Zalc B, Jacque C: Differential oligodendroglial expression of the tumor necrosis factor receptors in vivo and in vitro. J Neurochem 1995, 65:2377-2380
65. Zajicek JP, Wing M, Scolding NJ, Compston DAS: Interactions between oligodendrocytes and microglia: a major role for complement and tumour necrosis factor in oligodendrocyte adherence and killing. Brain 1992, 115:1611-1631
66. Barnes D, Munro PM, Youl BD, Prineas JW, McDonald WI: The longstanding MS lesion: a quantitative MRI and electron microscopic study. Brain 1991, 114:1271-1280
67. Cheng B, Christakos S, Mattson MP: Tumor necrosis factors protect neurons against metabolic-excitotoxic insults and promote maintenance of calcium homeostasis. Neuron 1994, 12:139-153
68. 2+ accummulation. Proc Natl Acad Sci USA 1995, 92:9328-9332
69. Bruce AJ, Boling W, Kindy MS, Peschon J, Kraemer PJ, Carpenter MK, Holtsberg FW, Mattson MP: Altered neuronal and microglial responses to excitotoxic and ischemic brain injury in mice lacking TNF receptors. Nat Med 1996, 2:788-794
70. Janzer RC, Raff MC: Astrocytes induce blood-brain barrier properties in endothelial cells. Nature 1987, 325:253-257